首页|血清HDAC10在宫颈癌患者血清中的表达及其与预后的关系

血清HDAC10在宫颈癌患者血清中的表达及其与预后的关系

扫码查看
目的 探讨组蛋白脱乙酰酶10(HDAC10)在宫颈癌患者血清中的表达及其与预后的关系.方法 选取2019年7月至2021年7月期间于湖北航天医院确诊和治疗的115例宫颈癌患者作为宫颈癌组,根据2年内患者死亡情况分为死亡组(31例)和生存组(84例);选取同院同期体检的110例健康女性作为对照组.采用酶联免疫吸附试验法检测血清HDAC10水平,血清HDAC10水平对宫颈癌患者死亡的预测价值采用受试者工作特征(ROC)曲线分析,宫颈癌死亡的因素采用多因素Cox回归分析.结果 宫颈癌组血清HDAC10水平低于对照组,差异具有统计学意义(P<0.05).国际妇产科联盟(FIGO)分期Ⅲ+Ⅳ期、病理分级为低分化、间质浸润深度>1/2、有淋巴结转移的宫颈癌患者血清HDAC10水平低于FIGO分期Ⅰ+Ⅱ期、病理分级中/高分化、间质浸润深度≤1/2、无淋巴结转移患者,差异具有统计学意义(P<0.05).死亡组FIGO分期Ⅲ+Ⅳ期、有淋巴结转移患者比例高于生存组,血清HDAC10水平低于生存组,差异具有统计学意义(P<0.05).血清HDAC10水平预测宫颈癌死亡的AUC为0.893,灵敏度为88.10%,特异度为83.90%.淋巴结转移是宫颈癌死亡的独立危险因素,HDAC10是宫颈癌死亡的保护因素(P<0.05).结论 宫颈癌患者血清HDAC10低表达,与FIGO分期、病理分级、间质浸润深度、淋巴结转移及预后相关,HDAC10可能作为预后评估潜在指标.
Expression of serum histone deacetylase 10 in cervical cancer patients and its relationship with prognosis
Objective To investigate the expression of histone deacetylase 10(HDAC10)of cervical cancer patients and its relationship with prognosis.Methods A total of 115 cervical cancer patients diagnosed and treated in Hubei Aerospace Hospital from July 2019 to July 2021 were collected as the cervical cancer group.According to the mortality situation of the patients within 2 years,they were grouped into a death group(31 cases)and a survival group(84 cases);a total of 110 women who underwent physical examinations in the same hospital during the same period were collected as the control group.Enzyme-linked immunosorbent assay(ELISA)was applied to detect serum HD AC 10 level,receiver operating characteristic(ROC)curve was used to analyze the predictive value of serum HD AC 10 level for mortality in cervical cancer patients,multivariate Cox regression was applied to analyze the factors of mortality in cervical cancer patients.Results The serum HDAC10 level in cervical cancer group was lower than control group with statistically significant difference(P<0.05).The serum HDAC 10 level in cervical cancer patients with International Federation of Gynecology and Obstetrics(FIGO)stage Ⅲ+Ⅳ,poorly differentiated pathological grade,depth of interstitial infiltration>1/2,lymph node metastasis were lower than that in patients with FIGO stage Ⅰ+Ⅱ,moderately/highly differentiated pathological grade,depth of interstitial infiltration≤1/2,and non-lymph node metastasis(P<0.05).The proportions of patients with FIGO stage Ⅲ+Ⅳ and lymph node metastasis in the death group were higher than those in the survival group,and the serum HDAC 10 level was significantly lower than the survival group,with statistically significant differences(P<0.05).The area under curve(AUC)of serum HDAC 10 level in predicting mortality in cervical cancer patients was 0.893,with a sensitivity of 88.10%and a specificity of 83.90%.Lymph node metastasis was an independent risk factor for mortality in cervical cancer patients,and HDAC 10 was a protective factor for mortality in cervical cancer patients(P<0.05).Conclusions The expression of serum HDAC 10 in cervical cancer patients is low,it is correlated with FIGO staging,pathological grading,depth of interstitial infiltration,lymph node metastasis,and prognosis.HDAC 10 may serve as a potential prognostic indicator.

Cervical cancerHistone deacetylase 10Clinical pathological characteristicsPrognosis

方志南、陶甜甜、闫丽

展开 >

湖北航天医院妇产科,武汉 432000

宫颈癌 组蛋白脱乙酰酶10 临床病理特征 预后

2024

中国性科学
中国性学会

中国性科学

CSTPCD
影响因子:1.394
ISSN:1672-1993
年,卷(期):2024.33(7)
  • 5